Gene · 5352
Papers1,610
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,610
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles. | Front Oncol | 2022 | 35965532 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| Volume and mobility of the infrapatellar fat pad during quasi-static knee extension after manual therapy in patients with knee osteoarthritis: a randomized control trial study. | J Phys Ther Sci | 2022 | 35937628 | PubTator, text mining | PubMed |
| A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes. | Front Immunol | 2022 | 35924232 | PubTator, text mining | PubMed |
| IL-6: The Link Between Inflammation, Immunity and Breast Cancer. | Front Oncol | 2022 | 35924148 | PubTator, text mining | PubMed |
| Development and Validation of a 6-Gene Hypoxia-Related Prognostic Signature For Cholangiocarcinoma. | Front Oncol | 2022 | 35924146 | PubTator, text mining | PubMed |
| Identification of a 3-Gene Model as Prognostic Biomarker in Patients With Gastric Cancer. | Front Oncol | 2022 | 35912206 | PubTator, text mining | PubMed |
| Characterizing the extracellular matrix transcriptome of cervical, endometrial, and uterine cancers. | Matrix Biol Plus | 2022 | 35898192 | PubTator, text mining | PubMed |
| High-Resolution Secretome Analysis of Chemical Hypoxia Treated Cells Identifies Putative Biomarkers of Chondrosarcoma. | Proteomes | 2022 | 35893766 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals the Pathogenic Relevance of Intracranial Atherosclerosis in Blood Blister-Like Aneurysms. | Front Immunol | 2022 | 35874788 | PubTator, text mining | PubMed |
| Engineering Modular 3D Liver Culture Microenvironments In Vitro to Parse the Interplay between Biophysical and Biochemical Microenvironment Cues on Hepatic Phenotypes. | Adv Nanobiomed Res | 2022 | 35872804 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells in Cavernous Hemangioma. | Front Cell Dev Biol | 2022 | 35865633 | PubTator, text mining | PubMed |
| The UIP/IPF fibroblastic focus is a collagen biosynthesis factory embedded in a distinct extracellular matrix. | JCI Insight | 2022 | 35852874 | PubTator, text mining | PubMed |
| Exploring links between 2-oxoglutarate-dependent oxygenases and Alzheimer's disease. | Alzheimers Dement | 2022 | 35852137 | PubTator, text mining | PubMed |
| Pyroptosis: A Novel Intervention Target in the Progression of Osteoarthritis. | J Inflamm Res | 2022 | 35845090 | PubTator, text mining | PubMed |
| PLOD3 contributes to HER-2 therapy resistance in gastric cancer through FoxO3/Survivin pathway. | Cell Death Discov | 2022 | 35835735 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Systematic analysis on expression quantitative trait loci identifies a novel regulatory variant in ring finger and WD repeat domain 3 associated with prognosis of pancreatic cancer. | Chin Med J (Engl) | 2022 | 35830250 | PubTator, text mining | PubMed |
| The Astounding World of Glycans from Giant Viruses. | Chem Rev | 2022 | 35820164 | PubTator, text mining | PubMed |
| Synovitis Ointment Improved Knee Osteoarthritis by Suppressing SDF-1/CXCR4 Signaling Pathway. | Evid Based Complement Alternat Med | 2022 | 35815270 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/papers?page=19